FDA Halts Plan for Vertex, CRISPR Therapeutics Sickle Cell Study

FDA Halts Plan for Vertex, CRISPR Therapeutics Sickle Cell Study

Submitted by admin on May 30, 2018 - 8:58pm
Source: 
Xconomy
News Tags: 
sickle cell disease
FDA
Vertex Pharmaceuticals
CRISPR Therapeutics
CTX001
stem cells
Headline: 
FDA Halts Plan for Vertex, CRISPR Therapeutics Sickle Cell Study
snippet: 

A Vertex Pharmaceuticals partnership with CRISPR Therapeutics to test a genetically engineered drug in patients as a treatment for sickle cell disease has been dealt a setback.

Do Not Allow Advertisers to Use My Personal information